Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1342-1347
Published online before print February 25, 2002, doi: 10.1161/hc1102.105288
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/11/1342    most recent
hc1102.105288v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Priori, S. G.
Right arrow Articles by Nastoli, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Priori, S. G.
Right arrow Articles by Nastoli, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
Medline Plus Health Information
*Cardiac Arrest
Related Collections
Right arrow Clinical genetics
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Epidemiology

(Circulation. 2002;105:1342.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Natural History of Brugada Syndrome

Insights for Risk Stratification and Management

Silvia G. Priori, MD, PhD; Carlo Napolitano, MD, PhD; Maurizio Gasparini, MD; Carlo Pappone, MD; Paolo Della Bella, MD; Umberto Giordano, MD; Raffaella Bloise, MD; Carla Giustetto, MD; Roberto De Nardis, MD; Massimiliano Grillo, MD; Elena Ronchetti, PhD; Giovanna Faggiano, MD; Janni Nastoli, BS

From Molecular Cardiology Laboratories, IRCCS Fondazione Salvatore Maugeri and University of Pavia, Pavia, Italy (S.G.P., C.N., R.B., M.G., E.R., G.F., J.N.); Unità Operativa di Elettrofisiologia, Istituto Clinico Humanitas, Rozzano, Italy (M.G.); Divisione di Aritmologia, IRCCS Ospedale San Raffaele, Milan, Italy (C.P.); Centro Cardiologico, Fondazione Monzino IRCCS, Milan, Italy (P.D.B.); Divisione di Cardiologia, Ospedale Civico Di Cristina ARNAS, Palermo, Italy (U.G.); Divisione di Cardiologia, Ospedale Molinette, University of Torino, Torino, Italy (C.G.); and Ospedale Cazzavillan, Arzignano, Italy (R.D.N.).

Correspondence to Silvia G. Priori, MD, PhD, Molecular Cardiology, Fondazione Salvatore Maugeri IRCCS, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy. E-mail spriori{at}fsm.it

Background Treatment of patients with Brugada syndrome is complicated by the incomplete information on the natural history of the disease related to the small number of cases reported. Furthermore, the value of programmed electrical stimulation (PES) for risk stratification is highly debated. The objective of this study was to search for novel parameters to identify patients at risk of sudden death.

Methods and Results Clinical data were collected for 200 patients (152 men, 48 women; age, 41±18 years) and stored in a dedicated database. Genetic analysis was performed, and mutations on the SCN5A gene were identified in 28 of 130 probands and in 56 of 121 family members. The life-table method of Kaplan-Meier used to define the cardiac arrest-free interval in patients undergoing PES failed to demonstrate an association between PES inducibility and spontaneous occurrence of ventricular fibrillation. Multivariate Cox regression analysis showed that after adjusting for sex, family history of sudden death, and SCN5A mutations, the combined presence of a spontaneous ST-segment elevation in leads V1 through V3 and the history of syncope identifies subjects at risk of cardiac arrest (HR, 6.4; 95% CI, 1.9 to 21; P<0.002).

Conclusions The information on the natural history of patients obtained in this study allowed elaboration of a risk-stratification scheme to quantify the risk for sudden cardiac death and to target the use of the implantable cardioverter-defibrillator.


Key Words: death, sudden • tachyarrhythmias • risk factors • genetics • fibrillation




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
S. Kamakura, T. Ohe, K. Nakazawa, Y. Aizawa, A. Shimizu, M. Horie, S. Ogawa, K. Okumura, K. Tsuchihashi, K. Sugi, et al.
Long-Term Prognosis of Probands With Brugada-Pattern ST-Elevation in Leads V1-V3
Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 495 - 503.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Veltmann, C. Wolpert, F. Sacher, P. Mabo, R. Schimpf, F. Streitner, J. Brade, F. Kyndt, J. Kuschyk, H. Le Marec, et al.
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges
Europace, October 1, 2009; 11(10): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Veltmann, C. Wolpert, R. Schimpf, P. Mabo, H. LeMarec, M. Borggrefe, and V. Probst
The ajmaline challenge and a strange ECG: reply
Europace, October 1, 2009; 11(10): 1406 - 1407.
[Full Text] [PDF]


Home page
Eur Heart JHome page
O. Catalano, S. Antonaci, G. Moro, M. Mussida, M. Frascaroli, M. Baldi, F. Cobelli, P. Baiardi, J. Nastoli, R. Bloise, et al.
Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities
Eur. Heart J., September 2, 2009; 30(18): 2241 - 2248.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Myerburg, V. Reddy, and A. Castellanos
Indications for implantable cardioverter-defibrillators based on evidence and judgment.
J. Am. Coll. Cardiol., August 25, 2009; 54(9): 747 - 763.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Pappone, A. Radinovic, F. Manguso, G. Vicedomini, S. Sala, F. M. Sacco, G. Ciconte, M. Saviano, M. Ferrari, E. Sommariva, et al.
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance
Eur. Heart J., August 20, 2009; (2009) ehp326v1.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. D. Krahn, J. S. Healey, V. Chauhan, D. H. Birnie, C. S. Simpson, J. Champagne, M. Gardner, S. Sanatani, D. V. Exner, G. J. Klein, et al.
Systematic Assessment of Patients With Unexplained Cardiac Arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER)
Circulation, July 28, 2009; 120(4): 278 - 285.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
N. P. Sidik, C. N. Quay, F. C. Loh, and L. Y. Chen
Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore
Europace, May 1, 2009; 11(5): 650 - 656.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
R. Shephard and C. Semsarian
Advances in the prevention of sudden cardiac death in the young
Therapeutic Advances in Cardiovascular Disease, April 1, 2009; 3(2): 145 - 155.
[Abstract] [PDF]


Home page
EuropaceHome page
C. Giustetto, S. Drago, P. G. Demarchi, P. Dalmasso, F. Bianchi, A. S. Masi, P. Carvalho, E. Occhetta, G. Rossetti, R. Riccardi, et al.
Risk stratification of the patients with Brugada type electrocardiogram: a community-based prospective study
Europace, April 1, 2009; 11(4): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Chagot, F. Potet, J. R. Balser, and W. J. Chazin
Solution NMR Structure of the C-terminal EF-hand Domain of Human Cardiac Sodium Channel NaV1.5
J. Biol. Chem., March 6, 2009; 284(10): 6436 - 6445.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. M. van Opstal, P. G.A. Volders, and H. J.G.M. Crijns
Provocation of silence
Europace, March 1, 2009; 11(3): 385 - 387.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.
Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 6 - 15.



Home page
J Am Coll CardiolHome page
B. Benito, A. Sarkozy, L. Mont, S. Henkens, A. Berruezo, D. Tamborero, D. Arzamendi, P. Berne, R. Brugada, P. Brugada, et al.
Gender Differences in Clinical Manifestations of Brugada Syndrome
J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1567 - 1573.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Morita, K. F. Kusano, D. Miura, S. Nagase, K. Nakamura, S. T. Morita, T. Ohe, D. P. Zipes, and J. Wu
Fragmented QRS as a Marker of Conduction Abnormality and a Predictor of Prognosis of Brugada Syndrome
Circulation, October 21, 2008; 118(17): 1697 - 1704.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Liu, M.-m. Wu, and H. H. Zakon
A Novel Na+ Channel Splice Form Contributes to the Regulation of an Androgen-Dependent Social Signal
J. Neurosci., September 10, 2008; 28(37): 9173 - 9182.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Francis and C. Antzelevitch
Atrial Fibrillation and Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. F. Kusano, M. Taniyama, K. Nakamura, D. Miura, K. Banba, S. Nagase, H. Morita, N. Nishii, A. Watanabe, T. Tada, et al.
Atrial Fibrillation in Patients With Brugada Syndrome: Relationships of Gene Mutation, Electrophysiology, and Clinical Backgrounds
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1169 - 1175.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P.-S. Chen and S. G. Priori
The Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1176 - 1180.
[Full Text] [PDF]


Home page
JCBHome page
J. S. Lowe, O. Palygin, N. Bhasin, T. J. Hund, P. A. Boyden, E. Shibata, M. E. Anderson, and P. J. Mohler
Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway
J. Cell Biol., January 10, 2008; 180(1): 173 - 186.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. L. Shang, A. E. Pfahnl, S. Sanyal, Z. Jiao, J. Allen, K. Banach, J. Fahrenbach, D. Weiss, W. R. Taylor, A. M. Zafari, et al.
Human Heart Failure Is Associated With Abnormal C-Terminal Splicing Variants in the Cardiac Sodium Channel
Circ. Res., November 26, 2007; 101(11): 1146 - 1154.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Sarkozy, T. Boussy, G. Kourgiannides, G.-B. Chierchia, S. Richter, T. De Potter, P. Geelen, F. Wellens, M. D. Spreeuwenberg, and P. Brugada
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome: reply
Eur. Heart J., November 2, 2007; 28(22): 2820 - 2821.
[Full Text] [PDF]


Home page
EuropaceHome page
K. P. Letsas, G. Gavrielatos, M. Efremidis, S. P. Kounas, G. S. Filippatos, A. Sideris, and F. Kardaras
Prevalence of Brugada sign in a Greek tertiary hospital population
Europace, November 1, 2007; 9(11): 1077 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Paul, J. Gerss, E. Schulze-Bahr, T. Wichter, C. Vahlhaus, A. A.M. Wilde, G. Breithardt, and L. Eckardt
Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data
Eur. Heart J., September 1, 2007; 28(17): 2126 - 2133.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Viskin and O. Rogowski
Asymptomatic Brugada syndrome: a cardiac ticking time-bomb?
Europace, September 1, 2007; 9(9): 707 - 710.
[Full Text] [PDF]


Home page
CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Hesse, C. S. Kondo, R. B. Clark, L. Su, F. L. Allen, C. T.M. Geary-Joo, S. Kunnathu, D. L. Severson, A. Nygren, W. R. Giles, et al.
Dilated cardiomyopathy is associated with reduced expression of the cardiac sodium channel Scn5a
Cardiovasc Res, August 1, 2007; 75(3): 498 - 509.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
CirculationHome page
V. Probst, I. Denjoy, P. G. Meregalli, J.-C. Amirault, F. Sacher, J. Mansourati, D. Babuty, E. Villain, J. Victor, J.-J. Schott, et al.
Clinical Aspects and Prognosis of Brugada Syndrome in Children
Circulation, April 17, 2007; 115(15): 2042 - 2048.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Schoenfeld
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Circulation, February 6, 2007; 115(5): 638 - 653.
[Full Text] [PDF]


Home page
CirculationHome page
M. Arnestad, L. Crotti, T. O. Rognum, R. Insolia, M. Pedrazzini, C. Ferrandi, A. Vege, D. W. Wang, T. E. Rhodes, A. L. George Jr, et al.
Prevalence of Long-QT Syndrome Gene Variants in Sudden Infant Death Syndrome
Circulation, January 23, 2007; 115(3): 361 - 367.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Sacher, V. Probst, Y. Iesaka, P. Jacon, J. Laborderie, F. Mizon-Gerard, P. Mabo, S. Reuter, D. Lamaison, Y. Takahashi, et al.
Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study
Circulation, November 28, 2006; 114(22): 2317 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Veltmann, R. Schimpf, C. Echternach, L. Eckardt, J. Kuschyk, F. Streitner, S. Spehl, M. Borggrefe, and C. Wolpert
A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification
Eur. Heart J., November 1, 2006; 27(21): 2544 - 2552.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Schulze-Bahr
Arrhythmia Predisposition: Between Rare Disease Paradigms and Common Ion Channel Gene Variants
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A67 - A78.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
D.-M. Niu, B. Hwang, H.-W. Hwang, N. H Wang, J.-Y. Wu, P.-C. Lee, J.-C. Chien, R.-C. Shieh, and Y.-T. Chen
A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect
J. Med. Genet., October 1, 2006; 43(10): 817 - 821.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
CirculationHome page
S. G. Priori and C. Napolitano
Molecular Underpinning of "Good Luck"
Circulation, August 1, 2006; 114(5): 360 - 362.
[Full Text] [PDF]


Home page
CirculationHome page
S. Poelzing, C. Forleo, M. Samodell, L. Dudash, S. Sorrentino, M. Anaclerio, R. Troccoli, M. Iacoviello, R. Romito, P. Guida, et al.
SCN5A Polymorphism Restores Trafficking of a Brugada Syndrome Mutation on a Separate Gene
Circulation, August 1, 2006; 114(5): 368 - 376.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Wren
Screening children with a family history of sudden cardiac death.
Heart, July 1, 2006; 92(7): 1001 - 1006.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. R. Cunha and P. J. Mohler
Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart
Cardiovasc Res, July 1, 2006; 71(1): 22 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. S. Pitt and B. Pitt
Aldosterone, ion channels, and sudden death: another piece of the circle?
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2176 - H2177.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Aiba, W. Shimizu, I. Hidaka, K. Uemura, T. Noda, C. Zheng, A. Kamiya, M. Inagaki, M. Sugimachi, and K. Sunagawa
Cellular Basis for Trigger and Maintenance of Ventricular Fibrillation in the Brugada Syndrome Model: High-Resolution Optical Mapping Study
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2074 - 2085.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Castro Hevia, C. Antzelevitch, F. Tornes Barzaga, M. Dorantes Sanchez, F. Dorticos Balea, R. Zayas Molina, M. A. Quinones Perez, and Y. Fayad Rodriguez
Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada Syndrome
J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1828 - 1834.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. A. Cesario and G. W. Dec
Implantable Cardioverter- Defibrillator Therapy in Clinical Practice
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1507 - 1517.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. M. Fish, D. R. Welchons, Y.-S. Kim, S.-H. Lee, W.-K. Ho, and C. Antzelevitch
Dimethyl Lithospermate B, an Extract of Danshen, Suppresses Arrhythmogenesis Associated With the Brugada Syndrome
Circulation, March 21, 2006; 113(11): 1393 - 1400.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. G. Priori and C. Napolitano
Role of Genetic Analyses in Cardiology: Part I: Mendelian Diseases: Cardiac Channelopathies
Circulation, February 28, 2006; 113(8): 1130 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. Bunch and M. J. Ackerman
Promoting Arrhythmia Susceptibility
Circulation, January 24, 2006; 113(3): 330 - 332.
[Full Text] [PDF]


Home page
CirculationHome page
A. Frustaci, S. G. Priori, M. Pieroni, C. Chimenti, C. Napolitano, I. Rivolta, T. Sanna, F. Bellocci, and M. A. Russo
Cardiac Histological Substrate in Patients With Clinical Phenotype of Brugada Syndrome
Circulation, December 13, 2005; 112(24): 3680 - 3687.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. A. Marill and P. T. Ellinor
Case 37-2005 -- A 35-Year-Old Man with Cardiac Arrest while Sleeping
N. Engl. J. Med., December 8, 2005; 353(23): 2492 - 2501.
[Full Text] [PDF]


Home page
CirculationHome page
M. Shah, F. G. Akar, and G. F. Tomaselli
Molecular Basis of Arrhythmias
Circulation, October 18, 2005; 112(16): 2517 - 2529.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N.A. M. Estes III
Sudden Cardiac Arrest From Primary Electrical Diseases: Provoking Concealed Arrhythmogenic Syndromes
Circulation, October 11, 2005; 112(15): 2220 - 2221.
[Full Text] [PDF]


Home page
CirculationHome page
A. D. Krahn, M. Gollob, R. Yee, L. J. Gula, A. C. Skanes, B. D. Walker, and G. J. Klein
Diagnosis of Unexplained Cardiac Arrest: Role of Adrenaline and Procainamide Infusion
Circulation, October 11, 2005; 112(15): 2228 - 2234.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. G. Meregalli, A. A.M. Wilde, and H. L. Tan
Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more?
Cardiovasc Res, August 15, 2005; 67(3): 367 - 378.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Brugada, R. Brugada, J. Brugada, S. G. Priori, C. Napolitano, P. Brugada, R. Brugada, J. Brugada, S. G. Priori, and C. Napolitano
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?
Circulation, July 12, 2005; 112(2): 279 - 292.
[Full Text] [PDF]


Home page
CirculationHome page
A. Kadish and M. Mehra
Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy
Circulation, June 21, 2005; 111(24): 3327 - 3335.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
T Rossenbacker, E Schollen, C Kuiperi, T J L de Ravel, K Devriendt, G Matthijs, D Collen, H Heidbuchel, and P Carmeliet
Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy
J. Med. Genet., May 1, 2005; 42(5): e29 - e29.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. G. Santambrogio, S. Mencherini, M. Fuardo, F. Caramella, and A. Braschi
The Surgical Patient with Brugada Syndrome: A Four-Case Clinical Experience
Anesth. Analg., May 1, 2005; 100(5): 1263 - 1266.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
T. T. Beery
The Genetics of Cardiac Arrhythmias
Biol Res Nurs, April 1, 2005; 6(4): 249 - 261.
[Abstract] [PDF]


Home page
CirculationHome page
C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, I. Gussak, H. LeMarec, K. Nademanee, A. R. Perez Riera, et al.
Brugada Syndrome: Report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
Circulation, February 8, 2005; 111(5): 659 - 670.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Eckardt, V. Probst, J. P.P. Smits, E. S. Bahr, C. Wolpert, R. Schimpf, T. Wichter, P. Boisseau, A. Heinecke, G. Breithardt, et al.
Long-Term Prognosis of Individuals With Right Precordial ST-Segment-Elevation Brugada Syndrome
Circulation, January 25, 2005; 111(3): 257 - 263.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J.-S. Hermida, I. Denjoy, G.èv. Jarry, S. Jandaud, C. Bertrand, and J. Delonca
Electrocardiographic predictors of Brugada type response during Na channel blockade challenge
Europace, January 1, 2005; 7(5): 447 - 453.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. J. Mohler, I. Rivolta, C. Napolitano, G. LeMaillet, S. Lambert, S. G. Priori, and V. Bennett
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes
PNAS, December 14, 2004; 101(50): 17533 - 17538.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Kies, T. Wichter, M. Schafers, M. Paul, K. P. Schafers, L. Eckardt, L. Stegger, E. Schulze-Bahr, O. Rimoldi, G. Breithardt, et al.
Abnormal Myocardial Presynaptic Norepinephrine Recycling in Patients With Brugada Syndrome
Circulation, November 9, 2004; 110(19): 3017 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. G Katritsis and A.J. Camm
Nonsustained ventricular tachycardia: where do we stand?
Eur. Heart J., July 1, 2004; 25(13): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-S. Hermida, I. Denjoy, J. Clerc, F. Extramiana, G. Jarry, P. Milliez, P. Guicheney, S. Di Fusco, J.-L. Rey, B. Cauchemez, et al.
Hydroquinidine therapy in Brugada syndrome
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1853 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Oto
Brugada sign: a normal variant or a bad omen? Insights for risk stratification and prognostication
Eur. Heart J., May 2, 2004; 25(10): 810 - 811.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Bordachar, S. Reuter, S. Garrigue, X. Cai, M. Hocini, P. Jais, M. Haissaguerre, and J. Clementy
Incidence, clinical implications and prognosis of atrial arrhythmias in brugada syndrome
Eur. Heart J., May 2, 2004; 25(10): 879 - 884.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R Valdivia, D. J Tester, B. A Rok, C.-b. J Porter, T. M Munger, A. Jahangir, J. C Makielski, and M. J Ackerman
A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs
Cardiovasc Res, April 1, 2004; 62(1): 53 - 62.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. G. Priori
Inherited Arrhythmogenic Diseases: The Complexity Beyond Monogenic Disorders
Circ. Res., February 6, 2004; 94(2): 140 - 145.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Brugada, R. Brugada, and P. Brugada
Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Circulation, December 23, 2003; 108(25): 3092 - 3096.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. P. DiMarco
Implantable Cardioverter-Defibrillators
N. Engl. J. Med., November 6, 2003; 349(19): 1836 - 1847.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. V. Pitzalis, M. Anaclerio, M. Iacoviello, C. Forleo, P. Guida, R. Troccoli, F. Massari, F. Mastropasqua, S. Sorrentino, A. Manghisi, et al.
QT-interval prolongation inright precordial leads: an additional electrocardiographic hallmark of Brugada syndrome
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1632 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.-S. Hermida, A. Leenhardt, B. Cauchemez, I. Denjoy, G. Jarry, F. Mizon, P. Milliez, J.-L. Rey, P. Beaufils, and P. Coumel
Decreased nocturnal standard deviation of averaged NN intervals: An independent marker to identify patients at risk in the Brugada Syndrome
Eur. Heart J., November 2, 2003; 24(22): 2061 - 2069.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Sakabe, A. Fujiki, M. Tani, K. Nishida, K. Mizumaki, and H. Inoue
Proportion and prognosis of healthy people with coved or saddle-back type ST segment elevation in the right precordial leads during 10 years follow-up
Eur. Heart J., August 2, 2003; 24(16): 1488 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. Rolf, H.-J. Bruns, T. Wichter, P. Kirchhof, M. Ribbing, K. Wasmer, M. Paul, G. Breithardt, W. Haverkamp, and L. Eckardt
The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol
Eur. Heart J., June 2, 2003; 24(12): 1104 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, J. A. Towbin, and K. Nademanee
Brugada syndrome: 1992-2002: A historical perspective
J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1665 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde
Genetic control of sodium channel function
Cardiovasc Res, March 15, 2003; 57(4): 961 - 973.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. A. Groenewegen, M. Firouzi, C. R. Bezzina, S. Vliex, I. M. van Langen, L. Sandkuijl, J. P.P. Smits, M. Hulsbeek, M. B. Rook, H. J. Jongsma, et al.
A Cardiac Sodium Channel Mutation Cosegregates With a Rare Connexin40 Genotype in Familial Atrial Standstill
Circ. Res., January 10, 2003; 92(1): 14 - 22.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
E. Moric, E. Herbert, M. Trusz-Gluza, A. Filipecki, U. Mazurek, and T. Wilczok
The implications of genetic mutations in the sodium channel gene (SCN5A)
Europace, January 1, 2003; 5(4): 325 - 334.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Antzelevitch, P. Brugada, J. Brugada, R. Brugada, W. Shimizu, I. Gussak, and A.R. Perez Riera
Brugada Syndrome: A Decade of Progress
Circ. Res., December 13, 2002; 91(12): 1114 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Committee Members, G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, et al.
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)
J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1703 - 1719.
[Full Text] [PDF]


Home page
CirculationHome page
G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, M. J. Silka, et al.
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)
Circulation, October 15, 2002; 106(16): 2145 - 2161.
[Full Text] [PDF]